IBSA Pharma recalls TIROSINT levothyroxine oral solution (50 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy details.
Subpotent Drug
IBSA Pharma recalled a specific levothyroxine oral solution product due to potential underactive drug strength. This could lead to improper thyroid hormone levels if used without medical supervision.
The product contains a subpotent drug, meaning it may not deliver the intended thyroid hormone dose. This could result in inadequate treatment if used without medical guidance. The risk is not immediate but requires careful monitoring by healthcare providers.
Prescription users of the recalled TIROSINT levothyroxine oral solution. Those with thyroid conditions requiring precise medication dosing are most at risk.
Check for the NDC number 71858-0115-5 on the packaging. The product was manufactured with lot numbers 220407 (expires 10/2023) or 220960 (expires 03/2024).
Look for the NDC number 71858-0115-5 and lot numbers 220407 or 220960 on the packaging.
The recall is for subpotent drug risk, meaning it may not deliver the intended dose. Consult your doctor before using this product.
Check for NDC 71858-0115-5 and lot numbers 220407 (expires 10/2023) or 220960 (expires 03/2024).
The recall does not specify a remedy. Contact IBSA Pharma for guidance on next steps.
We’ve drafted a message you can send IBSA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0338-2023 — IBSA Pharma IBSA Pharma Hello, I own a IBSA Pharma that is covered by recall D-0338-2023 from IBSA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
